Cytoxlab - Safety and Health Research
Citoxlab signs investment and partnership deal with Experimental Pharmacology and Oncology Berlin-Buch GmbH (EPO)
Investment in the German CRO, specialized in the preclinical assessment of new anticancer drugs, strengthens Citoxlab’s pharmacology portfolio, which will benefit from many synergies with preclinical safety and biomarkers services already provided by Citoxlab.
Citoxlab in FRANCE
B.P. 563 – 27005 Evreux cedex, France
Email : firstname.lastname@example.org
Phone : +33 (0)2 32 29 26 26